Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxShares Outstanding (Weighted Average)
Others
Ratios

Genprex (GNPX) EBITDA (2016 - 2025)

Genprex (GNPX) has 9 years of EBITDA data on record, last reported at -$3.3 million in Q3 2025.

  • For Q3 2025, EBITDA rose 22.59% year-over-year to -$3.3 million; the TTM value through Sep 2025 reached -$16.3 million, up 28.36%, while the annual FY2024 figure was -$21.2 million, 31.81% up from the prior year.
  • EBITDA reached -$3.3 million in Q3 2025 per GNPX's latest filing, up from -$4.7 million in the prior quarter.
  • Across five years, EBITDA topped out at -$3.3 million in Q3 2025 and bottomed at -$9.3 million in Q1 2023.
  • Average EBITDA over 5 years is -$5.7 million, with a median of -$5.8 million recorded in 2022.
  • Peak YoY movement for EBITDA: crashed 79.59% in 2022, then soared 44.46% in 2024.
  • A 5-year view of EBITDA shows it stood at -$6.7 million in 2021, then grew by 2.55% to -$6.6 million in 2022, then rose by 9.26% to -$6.0 million in 2023, then rose by 27.32% to -$4.3 million in 2024, then grew by 22.82% to -$3.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were -$3.3 million in Q3 2025, -$4.7 million in Q2 2025, and -$4.0 million in Q1 2025.